HDFC Bank drags Nifty 915 pts, 59 mutual funds with Rs 4.1 lakh crore hit
HDFC Bank has pulled the Nifty down by 915 points this year alone, making it the single biggest drag on the index. As many as 59 mutual funds holding a combined Rs…
HDFC Bank has pulled the Nifty down by 915 points this year alone, making it the single biggest drag on the index. As many as 59 mutual funds holding a combined Rs…
Indian benchmark indices opened flat to marginally higher on August 21, with the Sensex edging up 54 points to 77,592 and the Nifty climbing 17 points to 24,249. The gains came despite…
A 25-year analysis of Nifty 50 Total Return Index data by FundsIndia shows that investing a large corpus as a lump sum delivers a modest return advantage over a six-month systematic transfer…
Jagran Josh has published a 10-question quiz covering foundational Indian stock market concepts, aimed at young investors. The quiz tests knowledge of Sensex, which tracks 30 major BSE-listed companies, and Nifty 50,…
Gender pay parity remains elusive for most Nifty 50 companies. An analysis of annual reports by the Economic Times shows that in FY26, five out of every six companies (83%) paid their…
PC Jeweller shares rose on Tuesday even as the broader market extended its losing streak for the ninth straight session. The stock opened at Rs 9.65 and touched an intraday high of…
An economics professor at IIM Ranchi has a simple answer for those seeking stock tips: don't ask an economist. Despite a surge in retail investing that saw a Rs 100 investment in…
India's exclusion from the artificial intelligence boom may be ending its years-long run as a favoured emerging market for global investors, according to an analysis. The country has not produced a major…
India has replaced Indonesia as Asia's least-preferred stock market in a Bank of America survey of 98 fund managers managing $272 billion in assets, with 32% of respondents net underweight on Indian…
Invesco Mutual Fund has launched the India Pharma and Healthcare Fund, an NFO that will invest across pharmaceutical companies, hospitals, diagnostics, CDMOs, CROs, medical devices, healthcare services, insurance and allied segments. The…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.